Review of the third National Gene Technology Scheme 2017

Page last updated: Tuesday, 22 May 2018 - 12:35pm

The Legislative and Governance Forum on Gene Technology (the LGFGT) announced the review of the National Gene Technology Scheme in July 2017.

Please visit the review hub, being hosted on the Commonwealth Department of Health website, for details of the review including its Terms of Reference

As an interested stakeholder the Legislative and Governance Forum on Gene Technology (LGFGT) invites you to visit this website, subscribe to email updates, and become involved in the review. 

If you have any questions or concerns, please don’t hesitate to contact the Review team (02) 6289 3204, gene.technology.review@health.gov.au).

The consultation process has been organised in three phases aimed at identifying key issues for consideration, collaboratively exploring policy solutions to these issues, and finally providing an opportunity to comment on the findings:

Phase One – Written submissions (now closed)

  • Consultation was open from 25 July to 29 September 2017 (10 weeks). The purpose of this was to gain an understanding of key issues to be addressed through the review by seeking input from stakeholders (through a written submission process), and examining input into other reports and reviews.

Phase Two - Explore options and possible policy solutions (now closed)

  • Consultation was open from 6 November to 14 December 2017 (6 weeks) using the input from Phase one. Stakeholders were engaged through issues papers, workshops, forums, surveys, targeted meetings, market research and written submissions to explore options and develop solutions to the issues captured.

Phase Three - Preliminary report (now open)

Through the consultation processes to date, the Review has heard a diverse range of stakeholder views. These have led to the development of Review findings, which identify aspects of the Scheme that:

  • have operated successfully since its establishment and which should be maintained; and
  • may assist to future-proof and modernise the Scheme.

Public consultations are open from 28 March to 24 May 2018. The release of the Preliminary Report marks the start of this consultation process.

Stakeholders are invited to provide their feedback to inform the findings as outlined in the Preliminary Report. In particular, the Review is seeking comment to refine the findings, including whether there are any major considerations that have been missed.

Stakeholders can provide feedback through the online submission process.

Gene Technology Regulations 2001 review

The Gene Technology Regulator’s technical review of the Gene Technology Regulations 2001 (the Regulations) is also continuing. The technical review aims to provide clarity about whether organisms developed using a range of new technologies are subject to regulation as genetically modified organisms, and ensure that new technologies are regulated in a manner commensurate with the risks they pose.

While the technical review of the Regulations is limited to the current policy settings of the regulatory scheme, issues outside this scope may be considered by the Legislative and Governance Forum on Gene Technology (LGFGT) through the Review of the National Gene Technology Scheme.

The Review of the National Gene Technology Scheme is run by the LGFGT, independently of Office of the Gene Technology Regulator (OGTR,) and will involve future phases of engagement. OGTR is working toward publicising outcomes of the technical review of the Regulations in time for future consultations for the Review of the National Gene Technology Scheme.